Autoimmune pancreatitis overview: Difference between revisions
Iqra Qamar (talk | contribs) No edit summary |
Iqra Qamar (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Historical Perspective== | ==Historical Perspective== | ||
The concept of [[pancreas]] and [[pancreatic duct]] was first described by Johannes Wirsung of Padua in 1642. In 1761, Giovanni Morgagni described the clinical syndrome of severe upper [[abdominal pain]], [[vomiting]], and collapse. He is also credited with the earliest [[pathological]] recognition of [[cancer]] of the [[pancreas]]. In 1948, Eliason and Welty described [[distal]] [[pancreatectomy]] (DP). In 1980, Beger described duodenal-preserving pancreatic head [[resection]] (DPPHR) technique for [[chronic pancreatitis]] to decrease the morbidity of pancreatic head resection. In 1961, Sarles proposed [[autoimmunity]] as a pathogenetic mechanism of [[pancreatitis]]. In 1995, Yoshida proposed the term "autoimmune pancreatitis" for the first time. Autoimmune pancreatitis is also known as primary [[inflammatory]] [[pancreatitis]], lymphoplasmacytic sclerosing pancreatitis, pseudotumorous pancreatitis, [[chronic pancreatitis]] with irregular narrowing of the main [[pancreatic duct]], idiopathic chronic pancreatitis, and nonalcoholic duct destructive chronic pancreatitis. In 2009, the two types of autoimmune pancreatitis were first identified such as type 1 (lymphoplasmacytic sclerosing pancreatitis) and type 2 ([[idiopathic]] duct-centric [[pancreatitis]]). | |||
==Classification== | ==Classification== | ||
Revision as of 16:01, 5 January 2018
|
Autoimmune pancreatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune pancreatitis overview On the Web |
|
American Roentgen Ray Society Images of Autoimmune pancreatitis overview |
|
Risk calculators and risk factors for Autoimmune pancreatitis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]
Overview
Historical Perspective
The concept of pancreas and pancreatic duct was first described by Johannes Wirsung of Padua in 1642. In 1761, Giovanni Morgagni described the clinical syndrome of severe upper abdominal pain, vomiting, and collapse. He is also credited with the earliest pathological recognition of cancer of the pancreas. In 1948, Eliason and Welty described distal pancreatectomy (DP). In 1980, Beger described duodenal-preserving pancreatic head resection (DPPHR) technique for chronic pancreatitis to decrease the morbidity of pancreatic head resection. In 1961, Sarles proposed autoimmunity as a pathogenetic mechanism of pancreatitis. In 1995, Yoshida proposed the term "autoimmune pancreatitis" for the first time. Autoimmune pancreatitis is also known as primary inflammatory pancreatitis, lymphoplasmacytic sclerosing pancreatitis, pseudotumorous pancreatitis, chronic pancreatitis with irregular narrowing of the main pancreatic duct, idiopathic chronic pancreatitis, and nonalcoholic duct destructive chronic pancreatitis. In 2009, the two types of autoimmune pancreatitis were first identified such as type 1 (lymphoplasmacytic sclerosing pancreatitis) and type 2 (idiopathic duct-centric pancreatitis).